Brivaracetam News
Brivaracetam currently has 0 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Brivaracetam with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Briviact is indicated as adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalisation in adult and adolescent patients from 16 years of age with epilepsy.
- Evidence level: L5
- Predicted indications (20):
- visual epilepsy (99.5%)
- status epilepticus (99.4%)
- partial epilepsy (99.3%)
- startle epilepsy (99.2%)
- audiogenic seizures (99.2%)
- eating seizures (99.2%)
- thinking seizures (99.2%)
- orgasm-induced seizures (99.2%)
- micturation-induced seizures (99.2%)
- beta-ketothiolase deficiency (99.1%)
- adolescent/adult onset autosomal dominant epilepsy with auditory features (99.1%)
- guanidinoacetate methyltransferase deficiency (99.0%)
- reading seizures (98.9%)
- epilepsy with generalized tonic-clonic seizures (98.9%)
- 14q12 microdeletion syndrome (98.8%)
- Rett syndrome, congenital variant (98.8%)
- restless legs syndrome (98.1%)
- partial motor epilepsy (97.8%)
- epilepsy (96.2%)
- trigeminal nerve neoplasm (95.1%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.